What Can Pharma Do for Patients Post IRA?

Article

Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform.

Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform. Hagan notes there is a continuing need to have copay assistance because Medicare patients still face a $2K out of pocket cost, which is still a challenge for many of them.

Visit the PAN Foundation's "Everything You Need to Know About Medicare Reforms" for patients, providers and industry.

Recent Videos
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Related Content